![](jpg/1337378da89.jpg)
Sustainable Future Goals
Karger Publishers supports and endorses the United Nations Sustainable Development Goals.
The United Nations Sustainable Development Goals (UN SDGs) are a roadmap and a call to action for everybody to transform the world by 2030. We endorse the UN SDGs and particularly focus on two of the seventeen SDGs.
We have also signed the UN SDG Publishers Compact and are committed to achieving its ten goals. The Publishers Compact was launched at the Frankfurt Book Fair 2020. It is a pledge consisting of ten steps to which publishers can commit in order to help achieve the SDGs by 2030.
EcoVadis provides companies with holistic corporate social responsibility (CSR) ratings. The EcoVadis rating covers a wide range of non-financial management systems, including environmental impact, labor and human rights, ethics and sustainable procurement. Each company is assessed on the issues that are relevant to its size, location and industry. Karger Publishers has been awarded a bronze medal in recognition of its sustainability achievement. View the Karger EcoVadis Scorecard
#3 Good Health and Well-Being
We aim to connect and advance health sciences and our products and services cater to the information needs of the health sciences community. The content we deliver advances scientific discoveries that help to improve health and well-being.
As easy access to scientific knowledge is more important than ever to support research, especially in these times, we are continuing to drive forward the transition to Open Access (OA). After launching our first OA journal in 2007, the volume of OA journals and articles has grown continuously, and we aim to continue pursuing this strategy in the future. We have also made access to our Fast Facts medical handbook series free for registered users.
We consider it our duty to support the fight against the coronavirus. This is why we have been enabling free access to our research articles on COVID-19 since February 2020. In addition, the first issue of our new journal Kompass Nutrition & Dietetics explores how nutritional and behavioral measures may mitigate the risk of a severe course of coronavirus infection.
We have also taken measures to ensure the continued health and safety of our colleagues, customers, and partners in this unprecedented situation, as outlined by the Chairwoman of our Board of Directors, Gabriella Karger.
Within SDG 3, our content specifically focuses on the following Targets
Target 3.1:
By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.Selected Articles
-
Opportunities and Challenges in Global Perinatal Research
Duby J. · Sharma R. · Bhutta Z.A.
Neonatology 2018;114:93-102 (DOI:10.1159/000488310)
Ibarra-Hernandez M. · Alcantar-Vallin M.L. · Soto-Cruz A. · Jimenez-Alvarado P.M. · Villa-Villagran F. · Diaz-Avila J.J. · Tamez-Hernandez F. · Leon-Barrios M. · Chatrenet A. · Piccoli G.B. · Garcia-Garcia G.
Am J Nephrol 2019;49:386-396 (DOI:10.1159/000499964)
Akhtar H. · Patel C. · Abuelgasim E. · Harky A.
Gynecol Obstet Invest 2020;85:295-306 (DOI:10.1159/000509290)
Juul S.E. · Derman R.J. · Auerbach M.
Neonatology 2019;115:269-274 (DOI:10.1159/000495978)
Shah S. · Meganathan K. · Christianson A.L. · Harrison K. · Leonard A.C. · Thakar C.V.
Am J Nephrol 2020;51:216-226 (DOI:10.1159/000505894)
Target 3.2:
By 2030, end preventable deaths of newborns and children under five years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-five mortality to at least as low as 25 per 1,000 live births.Selected Articles
-
Factors Associated with Survival and Survival without Major Morbidity in Very Preterm Infants in Two Neonatal Networks: SEN1500 and NEOCOSUR
García-Muñoz Rodrigo F. · Fabres J. · Tapia J.L. · D’Apremont I.D. · San Feliciano L. · Zozaya Nieto C. · Figueras-Aloy J. · Mariani G. · Musante G. · Silvera F. · Zegarra J. · Vento M.
Neonatology 2021;118:289-296 (DOI:10.1159/000513079)
Schindler T. · Smyth J. · Bolisetty S. · Michalowski J. · Mallitt K.-A. · Singla A. · Lui K.
Neonatology 2021;118:274-281 (DOI:10.1159/000515415)
Van Wyk L. · Tooke L. · Dippenaar R. · Rhoda N. · Lloyd L. · Holgate S. · Alexander R. · Smith J.
Neonatology 2020;117:217-224 (DOI:10.1159/000506987)
Zhu X. · Feng Z. · Liu C. · Shi L. · Shi Y. · Ramanathan R. · on behalf of the NHFOV study group
Neonatology 2021;118:325-331 (DOI:10.1159/000515226)
Target 3.3:
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases, and other communicable disease.Selected Articles
-
Defining Outcomes of Tuberculosis (Treatment): From the Past to the Future
Günther G. · Heyckendorf J. · Zellweger J.P. · Reimann M. · Claassens M. · Chesov D. · van Leth F.
Respiration 2016;85:158-180 (DOI:10.1159/000516392)
Lima M.N. · Freitas R.J.R.X. · Passos B.A.B.R. · Darze A.M.G. · Castro-Faria-Neto H.C. · Maron-Gutierrez T.
Neuroimmunomodulation 2021;28:108-117 (DOI:10.1159/000515557)
Andersson A.-M. · Larsson M. · Stendahl O. · Blomgran R.
J Innate Immun 2020;12:235-247 (DOI:10.1159/000500861)
Dekmak A.S. · Yang X. · Zu Dohna H. · Buchon N. · Osta M.A.
J Innate Immun 2021;13:107-126 (DOI:10.1159/000511401)
Powell R.L.R. · Fox A. · Itri V. · Zolla-Pazner S.
J Innate Immun 2019;11:181-190 (DOI:10.1159/000494371)
Zutz A. · Schölz C. · Schneider S. · Pierini V. · Münchhoff M. · Sutter K. · Wittmann G. · Dittmer U. · Draenert R. · Bogner J.R. · Fackler O.T. · Keppler O.T.
J Innate Immun 2020;12:399-409 (DOI:10.1159/000504888)
Huang J. · Lok V. · Ngai C.H. · Chu C. · Patel H.K. · Thoguluva Chandraseka V. · Zhang L. · Chen P. · Wang S. · Lao X.-Q. · Tse L.A. · Xu W. · Zheng Z.-J. · Wong M.C.S.
Liver Cancer 2021;10:330-345 (DOI:10.1159/000515304)
Target 3.4:
By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.- Cardiovascular System
- Emergency Medicine
- Gastroenterology
- Genetics
- Hematology
- Nephrology
- Nutrition and Dietetics
- Neurology and Neuroscience
- Oncology
- Public Health
Selected Articles
-
The Epidemiology of Epilepsy
Beghi E.
Neuroepidemiology 2020;54:185-191 (DOI:10.1159/000503831)
Krishnamurthi R.V. · Ikeda T. · Feigin V.L.
Neuroepidemiology 2020;54:171-179 (DOI:10.1159/000506396)
Schreiner P. · Martinho-Grueber M. · Studerus D. · Vavricka S.R. · Tilg H. · Biedermann L. · on behalf of Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
Digestion 2020;101(suppl 1):120-135 (DOI:10.1159/000505368)
Rea K. · Dinan T.G. · Cryan J.F.
Neuropsychobiology 2020;79:50-62 (DOI:10.1159/000504495)
Morales E. · Galindo M. · Trujillo H. · Praga M.
Nephron 2021;145:1-13 (DOI:10.1159/000511268)
Gutiérrez E. · Carvaca-Fontán F. · Luzardo L. · Morales E. · Alonso M. · Praga M.
Nephron 2020;144:555-571 (DOI:10.1159/000509997)
Tummalapalli S.L. · Shlipak M.G. · Damster S. · Jha V. · Malik C. · Levin A. · Johnson D.W. · Bello A.K.
Am J Nephrol 2020;51:959-965 (DOI:10.1159/000511848)
Pradhan B. · Kjellstrom T. · Atar D. · Sharma P. · Kayastha B. · Bhandari G. · Pradhan P.K.
Cardiology 2019;143:37-48 (DOI:10.1159/000500853)
Thomssen C. · Balic M. · Harbeck N. · Gnant M.
Breast Care 2021;16:135-143 (DOI:10.1159/000/516114)
Carruba M.O. · Busetto L. · Bryant S. · Caretto A. · Farpour-Lambert N.J. · Fatati G. · Foschi D. · Giorgino F. · Halford J.C.G. · Lenzi A. · Malfi G. · O'Malley G. · Napier D. · Santini F. · Sbraccia P. · Spinato C. · Woodward E. · Nisoli E.
Obes Facts 2021;14:163-168 (DOI:10.1159/000514218)
Schwingshackl L. · Zähringer J. · Beyerbach J. · Werner S.W. · Heseker H. · Koletzko B. · Meerpohl J.J.
Ann Nutr Metab 2021;77:4-15 (DOI:10.1159/000515058)
Tersalvi G. · Biasco L. · Radovanovic D. · Rickli H. · Roffi M. · Eberli F. · Moccetti M. · Jeger R. · Moccetti T. · Erne P. · Pedrazzini G.
Cardiology 2020;145:757-765 (DOI:10.1159/000508928)
Target 3.5:
Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.Selected Articles
-
Effect of Assertive Community Treatment for Patients with Substance Use Disorder: A Systematic Review
Penzenstadler L. · Soares C. · Anci E. · Molodynski A. · Khazaal Y.
Eur Addict Res 2019;25:56-67 (DOI:10.1159/000496742)
Müller A. · Znoj H. · Moggi F.
Eur Addict Res 2019;25:213-223 (DOI:10.1159/000500520)
Betzler F. · Ernst F. · Helbig J. · Viohl L. · Roediger L. · Meister S. · Romanczuk-Seiferth N. · Heinz A. · Ströhle A. · Köhler S.
Eur Addict Res 2019;25:283-292 (DOI:10.1159/000501310)
Özgen H. · Spijkerman R. · Noack M. · Holtmann M. · Schellekens A.S.A. · van de Glind G. · Banaschewski T. · Barta C. · Begeman A. · Casas M. · Crunelle C.L. · Daigre Blanco C. · Dalsgaard S. · Demetrovics Z. · den Boer J. · Dom G. · Eapen V. · Faraone S.V. · Franck J. · González R.A. · Grau-López L. · Groenman A.P. · Hemphälä M. · Icick R. · Johnson B. · Kaess M. · Kapitány-Fövény M. · Kasinathan J.G. · Kaye S.S. · Kiefer F. · Konstenius M. · Levin F.R. · Luderer M. · Martinotti G. · Matthys F.I.A. · Meszaros G. · Moggi F. · Munasur-Naidoo A.P. · Post M. · Rabinovitz S. · Ramos-Quiroga J.A. · Sala R. · Shafi A. · Slobodin O. · Staal W.G. · Thomasius R. · Truter I. · van Kernebeek M.W. · Velez-Pastrana M.C. · Vollstädt-Klein S. · Vorspan F. · Young J.T. · Yule A. · van den Brink W. · Hendriks V.
Eur Addict Res 2020;26:223-232 (DOI:10.1159/000508385)
Rehm J. · Shield K.D.
Eur Addict Res 2021;27:1-8 (DOI:10.1159/000507017)
van Gils Y. · Franck E. · Dierckx E. · van Alphen S.P.J. · Dom G.
Eur Addict Res 2021;27:33-41 (DOI:10.1159/000507664)
Rovira P. · Kilian C. · Neufeld M. · Rumgay H. · Soerjomataram I. · Ferreira-Borges C. · Shield K.D. · Sornpaisarn B. · Rehm J.
Eur Addict Res 2021;27:189-197 (DOI:10.1159/000511899)
Drummond C. · Hillyard M. · Leonhardt M. · Wurst F. · Dom G. · Mann K. · Bramness J.G.
Eur Addict Res 2021;27:227-235 (DOI:10.1159/000512112)
Kuntsche S. · Kuntsche E.
Eur Addict Res 2021;27:42-48 (DOI:10.1159/000507665)
van Amsterdam J. · van den Brink W. · Pierce M.
Eur Addict Res (DOI:10.1159/000516165)
#7 Affordable and Clean Energy
We place great value on the use of sustainable energy and other resources.
Within SDG 7, we specifically focus on the following Targets
Target 7.2:
By 2030, increase substantially the share of renewable energy in the global energy mix.Renewable Energy
The energy we consume is produced through certified regional hydropower, and we make use of waste heat from a local refuse incineration plant in Basel. Similarly, the water we use is sourced locally at Hardwald and Lange Erlen.
Target 7.3:
By 2030, double the global rate of improvement in energy efficiency.Energy Efficiency
In 2008 and 2009, the insulation of the building at our headquarters was modernized to save energy.
This diagram shows the heat consumption of headquarter building at Allschwilerstrasse 10 in Basel. The heat consumption dropped after the modernization of the insulation of the building. Other variations are due to different winter temperatures over the years.
We use paper with an ecolabel from the Forest Stewardship Council (FSC) for our packaging material. Our publications are available digitally, and the small number of print copies has decreased continuously over the years. This also reduces the amount of energy used for shipping.
We raise awareness among our employees to promote the conscious use energy and other resources.
Testimonial
“Sustainability efforts, whether small or large, on an economic, social, and ecological level, are extremely important for Karger Publishers. Even as a medium-sized business, we would like to play our part. The SDG #3 Good Health and Well-Being is in line with our strategy, which aims to serve the information needs of our stakeholders in the ‘Cycle of Knowledge in Health Sciences’.”
Gabriella Karger, Publisher & Chairwoman of the Board of Directors